Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
Publication
, Journal Article
Van de Werf, F; Sinnaeve, P; Welsh, RC; Armstrong, PW
Published in: Circulation
February 27, 2024
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
February 27, 2024
Volume
149
Issue
9
Start / End Page
727 / 728
Location
United States
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Van de Werf, F., Sinnaeve, P., Welsh, R. C., & Armstrong, P. W. (2024). Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial". Circulation, 149(9), 727–728. https://doi.org/10.1161/CIRCULATIONAHA.123.067368
Van de Werf, Frans, Peter Sinnaeve, Robert C. Welsh, and Paul W. Armstrong. “Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".” Circulation 149, no. 9 (February 27, 2024): 727–28. https://doi.org/10.1161/CIRCULATIONAHA.123.067368.
Van de Werf F, Sinnaeve P, Welsh RC, Armstrong PW. Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial". Circulation. 2024 Feb 27;149(9):727–8.
Van de Werf, Frans, et al. “Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".” Circulation, vol. 149, no. 9, Feb. 2024, pp. 727–28. Pubmed, doi:10.1161/CIRCULATIONAHA.123.067368.
Van de Werf F, Sinnaeve P, Welsh RC, Armstrong PW. Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial". Circulation. 2024 Feb 27;149(9):727–728.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
February 27, 2024
Volume
149
Issue
9
Start / End Page
727 / 728
Location
United States
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology